Check your medication ASAP.
Key Points
- The FDA recalled levothyroxine sodium tablets nationwide due to reduced effectiveness.
- Affected tablets, sold by Major Pharmaceuticals, include various dosages and expiration dates.
- Dispose of recalled pills and contact your pharmacy for a refund or replacement if impacted.
There’s an active recall on levothyroxine, a medication used to treat an underactive thyroid due to hyperthyroidism or thyroid cancer. The U.S. Food and Drug Administration (FDA) states that the medication was sold nationwide.
The levothyroxine sodium tablets affected by this recall were distributed by Major Pharmaceuticals and sold in various dosages and strengths. The medication is recalled due to it being a “subpotent drug,” meaning the pills may not be as effective as prescribed.
The following Major Pharmaceuticals tablets are recalled right now, including impacted national drug codes (NDC), lot codes and expiration dates:
| Levothyroxine Sodium Tablets | NDC(s) | Lot Number(s) | Expiration Date(s) |
| 25 mcg (0.025 mg), 100 tablets | 0904-6949-61 | N02212 | 07/2026 |
| 50 mcg (0.050 mg), 100 tablets | 0904-6950-61 | N02200 | 10/2026 |
| 75 mcg (0.075 mg), 100 tablets | 0904-6951-61 | N02172; N02296; N02288 | 07/2026; 12/2026 |
| 88 mcg (0.088 mg), 100 tablets | 0904-6952-61 | N02310 | 01/2027 |
| 112 mcg (0.112 mg), 100 tablets | 0904-6954-61 | N02203 | 09/2026 |
| 125 mcg (0.125 mg), 100 tablets | 0904-6955-61 | N02266 | 11/2026 |
| 150 mcg (0.150 mg), 100 tablets | 0904-6956-61 | N02167 | 07/2026 |
| 25 mcg (0.025 mg), 10 tablets | 55154-3558-0; 0904-6949-61 | N02212A; N02212B; N02212 | 07/2026 |
| 50 mcg (0.050 mg), 10 tablets | 55154-3559-0; 0904-6950-61 | N02200A; N02200B; N02200 | 10/2026 |
| 75 mcg (0.075 mg), 10 tablets | 55154-3560-0; 0904-6951-61 | N02172A; N02172B; N02288A; N02288B; N02172; N02288 | 07/2026; 12/2026 |
| 125 mcg (0.125 mg), 10 tablets | 55154-3562-0; 0904-6955-61 | N02266A; N02266B; N02266 | 11/2026 |
| 150 mcg (0.150 mg), 10 tablets | 55154-3563-0; 0904-6956-61 | N02167A; N02167 | 07/2026 |
Check your medication, and if you have any of the recalled tablets on hand, dispose of them and contact your pharmacy for a refund or replacement. This recall has been classified as Class II, meaning that the thyroid medication “may cause temporary or medically reversible adverse health consequences.” Seek medical attention if you experience any health concerns after taking the recalled medication.
For questions about this recall, contact the FDA at 1-888-INFO-FDA (1-888-463-6332).
Comments are closed.